-
Oesophageal_Adenocarcinoma_Organoid_ATAC
Study
EGAS00001003890
-
Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles
Study
EGAS00001004063
-
Neoadjuvant immunotherapy leads to pathological responses in MMR proficient and MMR deficient early stage colon cancers
Study
EGAS00001004160
-
2015_AML_ETO
Study
EGAS00001002897
-
2015_AML_ETO_WGS_additional
Study
EGAS00001002898
-
SCLC tumor sequencing
Study
EGAS00001003985
-
The Precision Medicine in Liver Cancer across an Asia-pacific NETwork (PLANET)
Study
EGAS00001003813
-
Circulating tumor cells Exome sequencing from breast cancer
Study
EGAS00001005228
-
Targeted sequencing of breast cancers with germline BRCA1/2 mutations
Study
EGAS00001004182
-
Whole exome sequencing of advanced gastric cancer
Study
EGAS00001004086
-
Comparison of structural variations from 10X Genomics linked-reads and conventional Illumina short-reads sequencing
Study
EGAS00001004093
-
The miR-185/PAK6 Axis Predicts Therapy Response and Regulates Survival of Drug-Resistant Leukemic Stem Cells in Chronic Myeloid Leukemia
Study
EGAS00001004153
-
Preservation of stemness in high-grade serous ovarian cancer organoids requires low Wnt environment
Study
EGAS00001003821
-
SS18-SSX-mediated hijacking of BAF complexes drives synovial sarcoma
Study
EGAS00001002920
-
Whole-exome sequencing and microRNA profiling predicted relapse risk of stage I lung adenocarcinomas
Study
EGAS00001004461
-
Prospective high-throughput genome profiling in advanced cancers:
Study
EGAS00001004554
-
Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer
Study
EGAS00001003830
-
Metastatic Adult Pancreatoblastoma: Multimodal Treatment and Molecular Characterization of a Very Rare Disease (NCT MASTER)
Study
EGAS00001004157
-
Adult-type Granulosa Cell Tumour of the Ovary
Study
EGAS00001005414
-
Molecular evolution and clinical trajectories of prostate cancer identifies novel markers for risk stratification
Study
EGAS00001002923
-
Adult granulosa cell tumor WGS data cohort with corresponding reference germline WGS data
Study
EGAS00001004249
-
pancreatic ductal adenocarcinoma exomes in study: Pro-immunogenic Impact of MEK inhibition combined with an anti-CD40 immunostimulatory antibody
Study
EGAS00001004196
-
Somatic_mutation_and_clonal_evolution_in_the_human_bladder_TGS
Study
EGAS00001002659
-
Single-cell transcriptome sequencing of regulatory and conventional T cells in breast cancer patients and healthy individuals.
Study
EGAS00001002933
-
Longitudinal therapy monitoring of ALK-positive non-small cell lung cancer (copy number, cell-free DNA)
Study
EGAS00001004276
-
Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer
Study
EGAS00001003388
-
RNA Sequencing of Colorectal Liver Metastases
Study
EGAS00001002945
-
Lymphoctye_colony_WGS
Study
EGAS00001002948
-
Genomic Rearrangements in Pediatric Cancer
Study
EGAS00001005312
-
Studying the single cell characteristics of pancreatic cancer
Study
EGAS00001003889
-
Multimodal Genomic Features Predict Outcome of Immune Checkpoint Blockade in Non-small Cell Lung Cancer
Study
EGAS00001003892
-
WES data from 165 tumor/germline samples with muscle invasive bladder cancer.
Study
EGAS00001004507
-
Identification of hypermutation and defective mismatch repair in ctDNA from metastatic prostate cancer
Study
EGAS00001003899
-
Targeted sequencing DDR genes in cancer stem cells
Study
EGAS00001004892
-
Colorectal adenomas, NKI-AvL TGO series Stool-Proteomics
Study
EGAS00001002953
-
Contribution of allelic imbalance to colorectal cancer
Study
EGAS00001002966
-
Identification of Therapeutic Targets in Rhabdomyosarcoma Through Integrated Genomic, Epigenomic, and Proteomic Analyses
Study
EGAS00001002967
-
Single cell RNAseq of PBMC from bladder cancer patients
Study
EGAS00001004008
-
Targeted_sequencing_of_embryonic_variants___Warm_Autopsy
Study
EGAS00001003952
-
Partner-independent fusion gene detection by multiplexed CRISPR/Cas9 enrichment and long-read Nanopore sequencing
Study
EGAS00001003964
-
Spiradenocarcinoma
Study
EGAS00001001799
-
METABRIC: Data from Batra et al (2021); DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation
Study
EGAS00001004327
-
Single cell exome sequencing of lung adenocarcinoma
Study
EGAS00001002972
-
Targeted sequencing about core genes involved in telomere biology in colorectal cancer patients
Study
EGAS00001002977
-
Dissecting intratumor heterogeneity of nodal B cell lymphoma on the transcriptional, genetic, and drug response level
Study
EGAS00001004335
-
Identification of the mutational consequences of precancerous liver disease (including alcohol abuse) on the genomes of human adult stem cells.
Study
EGAS00001002983
-
Molecular determinants of response to PD-L1 blockade across tumor types
Study
EGAS00001004343
-
Tumor-specific expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer
Study
EGAS00001004001
-
Role_of_HPV_and_Interferon_in_APOBEC_mutational_signature
Study
EGAS00001002988
-
Phylogenetic reconstruction of breast cancer
Study
EGAS00001004356
-
Single-cell RNA sequencing of 22 Hodgkin lymphoma tumors and 5 reactive lymph nodes
Study
EGAS00001004085
-
Host whole genome variations are associated with neurocognitive outcome in survivors of pediatric medulloblastoma
Study
EGAS00001002996
-
Rapid response of APC/TP53/KRAS mutated stage IV colorectal cancer under FOLFIRI + Bevacizumab detected by liquid biopsy: a case report
Study
EGAS00001004088
-
Whole genome, exome and transcriptome analysis to guide individualized cancer interpretation
Study
EGAS00001004013
-
Mapping the breast cancer metastatic cascade onto circulating tumour DNA using genetic and epigenetic clonal tracking
Study
EGAS00001004014
-
Bulk RNAseq gene expression of baseline tumors from metastatic urothelial bladder cancer patients (IMvigor210) and metastatic renal cell carcinoma (IMmotion150)
Study
EGAS00001004386
-
Effect_of_FAM50_knockout_on_the_transcriptome
Study
EGAS00001004836
-
Matching of actionable mutations with therapies in cancer patients: comparison of three commercial decision support platforms
Study
EGAS00001004383
-
Whole genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
Study
EGAS00001004379
-
WGS
Study
EGAS00001007211
-
Exploring_the_landscape_of_somatic_mutations_in_normal_tissue___BD___WGS
Study
EGAS00001003014
-
Genomic study of an AT-AML
Study
EGAS00001004392
-
RNA-seq data from Non Small Cell Lung Cancer (NSCLC) samples
Study
EGAS00001004032
-
Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer
Study
EGAS00001004030
-
Single-cell RNA-sequencing reveals that glioblastoma recapitulates a normal neurodevetlopmental hierarchy
Study
EGAS00001004422
-
Somatic_mutation_and_clonal_evolution_in_the_human_testes___WES
Study
EGAS00001003023
-
Immunogenomics of colorectal cancer response to immune checkpoint blockade
Study
EGAS00001004438
-
Heterogeneous metabolic signatures are linked to cancer cell differentiation in colorectal cancer
Study
EGAS00001004064
-
Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown Primary with Neuroendocrine Differentiation
Study
EGAS00001003026
-
Whole_Genome_Sequencing_of_Human_Organoid_Lines
Study
EGAS00001003538
-
RNAseq
Study
EGAS00001007212
-
Whole exome sequencing data of germline and two independent primary leukemias of five patients
Study
EGAS00001001889
-
Whole exome sequencing on Pediatric MDS patients
Study
EGAS00001005432
-
Mutations in the RAS/MAPK pathway drive replication repair deficient hypermutated tumors and confer sensitivity to MEK inhibition
Study
EGAS00001005008
-
Comprehensive pharmacogenomic characterization of gastric cancer
Study
EGAS00001004106
-
Human genomic and phenotypic synthetic data for the study of rare diseases
Study
EGAS00001005702
-
Combination_Immune_Checkpoint_Inhibition_in_Australian_Rare_Cancers_WES
Study
EGAS00001005709
-
MicroRNA profiling by next-generation sequencing for colorectal cancer screening
Study
EGAS00001005030
-
Accurate mapping of mitochondrial DNA deletions and duplications using deep sequencing
Study
EGAS00001004380
-
Somatic mutations in endometriosis and normal uterine endometrium
Study
EGAS00001003095
-
RNA-seq data from 121 tumor samples with muscle invasive bladder cancer.
Study
EGAS00001004505
-
Exploring_the_landscape_of_somatic_mutations_in_normal_tissue___GI___MAP___WGS
Study
EGAS00001004122
-
Germline elongator mutations in sonic hedgehog medulloblastoma
Study
EGAS00001004126
-
DERMATLAS__Porocarcinoma_RNAseq
Study
EGAS00001005721
-
Characterization of four subtypes in morphologically normal tissue excised proximal and distal to breast cancer
Study
EGAS00001004510
-
Cancer immune control needs senescence induction by Stat1 dependent cell cycle regulator pathways in tumours
Study
EGAS00001004151
-
FAM50A_Disruption_in_TOV21G_Cells___RNAseq
Study
EGAS00001004156
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma
Study
EGAS00001004551
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma - RNA-seq
Study
EGAS00001004552
-
Molecular_risk_stratification_in_patients_with_T1_colorectal_cancer_WES
Study
EGAS00001005734
-
Mutational signatures in head and neck cancer (H019)
Study
EGAS00001004588
-
The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer (CIN3+)
Study
EGAS00001005078
-
Panbody_nanoseq
Study
EGAS00001005521
-
'KOREAN' never-smoker female adenocarcinoma RNA-seq
Study
EGAS00001003789
-
16 Year Life History and Genomic Evolution of an ER+ HER2- Breast Cancer
Study
EGAS00001004624
-
Detection of Cancer Mutations by Urine Liquid Biopsy in Bladder Cancer Patients
Study
EGAS00001005758
-
Mutational landscape of eccrine porocarcinoma (sweat gland tumour)
Study
EGAS00001004632
-
CRISPR transduction of iPS cells
Study
EGAS00001005102
-
Sequencing of cancer autopsies and ctDNA
Study
EGAS00001005109
-
Genomic analysis of patient-derived xenograft models reveals intratumor-heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib
Study
EGAS00001004666